GlassScriptPhysician profile
Megan Schwartz
NPI 1538665229
$4,591.92
in general payments reported to CMS, 2019-2025
33 companies · $1,906 in 2025
The $1,906 reported for 2025 was more than what 92% of Addiction Medicine (Family Medicine) providers received nationally (typical 2025 total: $143).
See the full distribution for Addiction Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $255 · 2023: $880 · 2024: $1,550 · 2025: $1,906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,337.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $948.77 | 2022-2025 | Vraylar, Ubrelvy |
| Glaxosmithkline, LLC. | $422.11 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Lilly USA, LLC | $367.63 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Viiv Healthcare Company | $317.28 | 2024-2025 | Apretude |
| Amgen INC. | $243.71 | 2024-2025 | Evenity, Repatha, Otezla |
| Pfizer INC. | $242.42 | 2023-2025 | |
| Gilead Sciences, INC. | $224.34 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $201.90 | 2024-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $190.08 | 2024-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $160.47 | 2022-2025 | Verquvo, Capvaxive, Gardasil 9 |
| Inspire Medical Systems, INC. | $158.16 | 2022-2024 | Inspire |
| Janssen Pharmaceuticals, INC | $114.40 | 2023-2025 | Spravato, Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $112.48 | 2023-2025 | |
| Astellas Pharma US INC | $96.10 | 2024-2025 | Veozah |
| Novo Nordisk INC | $95.68 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $79.16 | 2022-2025 | Nexplanon |
| Indivior INC. | $70.78 | 2023 | Sublocade |
| Astrazeneca Pharmaceuticals LP | $67.79 | 2024-2025 | Airsupra, Breztri |
| Hologic Sales and Service, LLC | $62.63 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Medtronic, INC. | $62.35 | 2022-2025 | Inceptiv, Minimed 780g |
| Boston Scientific Corporation | $52.16 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Xeris Pharmaceuticals, INC. | $45.95 | 2023-2024 | Gvoke Hypopen |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $40.46 | 2025 | Caplyta |
| Cranial Technologies, INC | $36.32 | 2022-2023 | Doc Band |
| Idorsia Pharmaceuticals US INC | $29.09 | 2023-2024 | Quviviq |
| Phathom Pharmaceuticals, INC. | $23.17 | 2025 | Voquezna |
| Verona Pharma, INC. | $22.00 | 2025 | Ohtuvayre |
| Shield Therapeutics INC | $20.46 | 2024 | |
| Axsome Therapeutics, INC. | $20.04 | 2025 | Auvelity |
| Dexcom, INC. | $19.31 | 2025 | Dexcom G6 Transmitter |
| Sanofi Pasteur INC. | $18.59 | 2024 | |
| Verity Pharmaceuticals INC. | $13.94 | 2025 | Tlando |
| Takeda Pharmaceuticals U.S.A., INC. | $12.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.